Panel Detail

Sunday, September 9, 2012
11:40 AM - 12:30 PM

Advances Against the Crafty Cancer Cell


Margaret Foti, CEO, American Association for Cancer Research


Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer Research and Professor of Biology, MIT; Investigator, Howard Hughes Medical Institute
Steven Rosenberg, Chief, Surgery Branch, National Cancer Institute
Charles Sawyers, Investigator, Howard Hughes Medical Institute; Chair, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center
Owen Witte, Director, Broad Stem Cell Research Center; Investigator, Howard Hughes Medical Institute; Professor, Microbiology and Pharmacology, University of California, Los Angeles
Progress in the "War on Cancer" was slow but steady for much of the past 40 years. In the last decade, however, the pace of innovation has accelerated and death rates for the most common cancers have started to decline. In this panel, four of the world's leading cancer investigators describe the advanced techniques they and others developed through collaborations among academic research centers, private industry and the National Institutes of Health. Progress in areas such as molecularly targeted cancer drugs gives patients substantially greater hope than was thought possible even a few years ago. New understanding of the genetic events that contribute to cancer, the survival strategies of tumors and body's immune response, adoptive immunotherapy and other treatment options emerging from their laboratories are achieving increasing success in holding back cancer progression and turning once-fatal diseases into treatable conditions.

Panel Video

th craftycancer

Click image above to play video